- Home
- CLST vs KRON Comparison
CLST vs KRON Comparison
Compare CLST & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLST
- KRON
- Stock Information
- Founded
- CLST 1922
- KRON 2017
- Country
- CLST United States
- KRON United States
- Employees
- CLST N/A
- KRON N/A
- Industry
- CLST
- KRON Medicinal Chemicals and Botanical Products
- Sector
- CLST
- KRON Health Care
- Exchange
- CLST Nasdaq
- KRON Nasdaq
- Market Cap
- CLST 48.8M
- KRON 41.0M
- IPO Year
- CLST N/A
- KRON 2020
- Fundamental
- Price
- CLST $12.00
- KRON $0.68
- Analyst Decision
- CLST
- KRON Buy
- Analyst Count
- CLST 0
- KRON 3
- Target Price
- CLST N/A
- KRON $1.63
- AVG Volume (30 Days)
- CLST 5.1K
- KRON 925.7K
- Earning Date
- CLST 04-24-2025
- KRON 06-10-2025
- Dividend Yield
- CLST N/A
- KRON N/A
- EPS Growth
- CLST N/A
- KRON N/A
- EPS
- CLST 0.57
- KRON N/A
- Revenue
- CLST $11,257,000.00
- KRON $9,192,000.00
- Revenue This Year
- CLST N/A
- KRON N/A
- Revenue Next Year
- CLST N/A
- KRON N/A
- P/E Ratio
- CLST $21.12
- KRON N/A
- Revenue Growth
- CLST 200.91
- KRON 21.16
- 52 Week Low
- CLST $10.67
- KRON $0.65
- 52 Week High
- CLST $12.40
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- CLST 62.86
- KRON 34.59
- Support Level
- CLST $11.62
- KRON $0.66
- Resistance Level
- CLST $12.00
- KRON $0.75
- Average True Range (ATR)
- CLST 0.14
- KRON 0.03
- MACD
- CLST 0.02
- KRON 0.00
- Stochastic Oscillator
- CLST 50.00
- KRON 26.32
About CLST Catalyst Bancorp Inc.
Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of small molecule therapeutics to address deregulated transcription, a hallmark of cancer and autoimmune diseases.